After months of temporary supply constraints for its blood pressure cuffs, Baxter said it will finally lift all allocations for Welch Allyn BP cuffs beginning next week.
The medical device maker said its BP cuff manufacturing operations remain at 100% production on a 24/7 schedule, producing volumes and shipments consistent with what it called pre-disruption amounts.
It also said that it has made significant progress in its capacity expansion plan, including the installation of one blood pressure cuff machine in the U.S., which has been fully operational and shipping cuffs since March 14. Baxter expects this machine will be followed by another U.S.-based product machine that it expects to be fully operational in late May.
Baxter last year said it was experiencing a temporary constraint on raw material availability for its blood pressure cuff production out of its manufacturing plant in Mexico. That comes after U.S. imports of raw materials into Mexico were temporarily halted, which led to a pause in production at its plant.
